NEPHROLOGY / CLINICAL RESEARCH
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
The aim of this study was to investigate the association between the systemic inflammation response index (SIRI) and all-cause and cardiovascular disease (CVD) mortality in maintenance hemodialysis (MHD) patients.

Material and methods:
371 MHD patients were included in this retrospective study. Time-dependent receiver operating characteristic (ROC) curve analysis was used to evaluate the predictive value of SIRI. Patients were categorized into two groups based on the median SIRI value. Kaplan-Meier survival analysis was used to compare the difference in survival rate. Cox regression analysis was used to analyze all-cause and CVD mortality risk factors, and nomograms were developed.

Results:
The average age of the patients was 60.71 ±15.34 years, and the median follow-up was 42 months. 157 patients died. SIRI had predictive value for all-cause and CVD mortality. The AUC of the SIRI to predict all-cause mortality was 0.698, 0.664, 0.713, and 0.900 at 1, 3, 5, and 10 years, respectively. For CVD mortality, the AUC of the SIRI was 0.678, 0.667, 0.717, and 0.906 at 1, 3, 5, and 10 years, respectively. Kaplan-Meier survival analysis showed that patients with high SIRI values had a significantly lower survival rate. Multivariate Cox regression analysis showed that SIRI > 1.88 was an independent risk factor for all-cause and CVD mortality.

Conclusions:
SIRI can independently predict all-cause and CVD mortality in MHD patients, which has important value for prognosis.
REFERENCES (27)
1.
Saran R, Robinson B, Abbott KC, et al. US Renal Data System 2019 Annual Data Report: epidemiology of kidney disease in the United States. Am J Kidney Dis 2020; 75 (1 Suppl 1): A6-7.
 
2.
Wang Y, Gao L. Inflammation and cardiovascular disease associated with hemodialysis for end-stage renal disease. Front Pharmacol 2022; 13: 800950.
 
3.
Li S, Lan X, Gao H, et al. Systemic Inflammation Response Index (SIRI), cancer stem cells and survival of localised gastric adenocarcinoma after curative resection. J Cancer Res Clin Oncol 2017; 143: 2455-68.
 
4.
Qi Q, Zhuang L, Shen Y, et al. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy. Cancer 2016; 122: 2158-67.
 
5.
Zhang Y, Xing Z, Zhou K, Jiang S. The predictive role of Systemic Inflammation Response Index (SIRI) in the prognosis of stroke patients. Clin Interv Aging 2021; 16: 1997-2007.
 
6.
Li J, He D, Yu J, et al. Dynamic status of SII and SIRI alters the risk of cardiovascular diseases: evidence from Kailuan Cohort Study. J Inflamm Res 2022; 15: 5945-57.
 
7.
Adamsson Eryd S, Smith JG, Melander O, Hedblad B, Engstrom G. Incidence of coronary events and case fatality rate in relation to blood lymphocyte and neutrophil counts. Arterioscler Thromb Vasc Biol 2012; 32: 533-9.
 
8.
Kato A, Takita T, Furuhashi M, Maruyama Y, Kumagai H, Hishida A. Blood monocyte count is a predictor of total and cardiovascular mortality in hemodialysis patients. Nephron Clin Pract 2008; 110: c235-43.
 
9.
Fei J, Fu L, Li Y, et al. Reduction of lymphocyte count at early stage elevates severity and death risk of COVID-19 patients: a hospital-based case-cohort study. Arch Med Sci 2023; 19: 1303-13.
 
10.
Afari ME, Bhat T. Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update. Expert Rev Cardiovasc Ther 2016; 14: 573-7.
 
11.
Zsom L, Faludi M, Fulop T, Dossabhoy NR, Rosivall L, Tapolyai MB. The association of overhydration with chronic inflammation in chronic maintenance hemodiafiltration patients. Hemodial Int 2019; 23: 384-91.
 
12.
Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
 
13.
Sato H, Takeuchi Y, Matsuda K, et al. Pre-dialysis neutrophil-lymphocyte ratio, a novel and strong short-term predictor of all-cause mortality in patients with diabetic nephropathy: results from a single-center study. Ther Apher Dial 2017; 21: 370-7.
 
14.
Xiang F, Chen R, Cao X, et al. Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study. Hemodial Int 2018; 22: 82-92.
 
15.
Zhao S, Dong S, Qin Y, Wang Y, Zhang B, Liu A. Inflammation index SIRI is associated with increased all-cause and cardiovascular mortality among patients with hypertension. Front Cardiovasc Med 2022; 9: 1066219.
 
16.
Li J, Li Y, Zou Y, et al. Use of the systemic inflammation response index (SIRI) as a novel prognostic marker for patients on peritoneal dialysis. Ren Fail 2022; 44: 1227-35.
 
17.
Yan Z, Li L. Prognostic value of Systemic Inflammatory Response Index for the prognosis of diabetic maintenance hemodialysis patients: a retrospective observational study. Int J Gen Med 2023; 16: 3613-22.
 
18.
Liberale L, Badimon L, Montecucco F, Luscher TF, Libby P, Camici GG. Inflammation, aging, and cardiovascular disease: JACC review topic of the week. J Am Coll Cardiol 2022; 79: 837-47.
 
19.
Soysal P, Arik F, Smith L, Jackson SE, Isik AT. Inflammation, frailty and cardiovascular disease. Adv Exp Med Biol 2020; 1216: 55-64.
 
20.
Paraskevaidis I, Farmakis D, Papingiotis G, Tsougos E. Inflammation and heart failure: searching for the enemy-reaching the entelechy. J Cardiovasc Dev Dis 2023; 10: 19.
 
21.
Wu J, Guo N, Chen X, Xing C. Coexistence of micro-inflammatory and macrophage phenotype abnormalities in chronic kidney disease. Int J Clin Exp Pathol 2020; 13: 317-23.
 
22.
Friedrich B, Alexander D, Janessa A, Haring HU, Lang F, Risler T. Acute effects of hemodialysis on cytokine transcription profiles: evidence for C-reactive protein-dependency of mediator induction. Kidney Int 2006; 70: 2124-30.
 
23.
Mandic A, Cavar I, Skoro I, et al. Body composition and inflammation in hemodialysis patients. Ther Apher Dial 2017; 21: 556-64.
 
24.
Marants R, Qirjazi E, Lai KB, et al. Exploring the link between hepatic perfusion and endotoxemia in hemodialysis. Kidney Int Rep 2021; 6: 1336-45.
 
25.
Pawelec G, Goldeck D, Derhovanessian E. Inflammation, ageing and chronic disease. Curr Opin Immunol 2014; 29: 23-8.
 
26.
Kanda E, Kato A, Masakane I, Kanno Y. A new nutritional risk index for predicting mortality in hemodialysis patients: nationwide cohort study. PLoS One 2019; 14: e0214524.
 
27.
Zhu M, Dou L, Zhu M, et al. Variability of serum phosphorus and its association with mortality among hemodialysis patients. Clin Nephrol 2018; 90: 79-86.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top